## Trump Administration Prepares 100% Tariff Order on Patented Drug Imports, Exemptions for MFN Deals
The Trump administration has prepared an executive order to impose a 100% tariff on imports of patented medicines and their active pharmaceutical ingredients, a move that could be announced as soon as Thursday. This aggressive trade action directly targets the pharmaceutical supply chain, though the timeline and final details remain subject to change. The order is not a blanket measure; it reportedly offers several pathways for drugmakers to avoid the punitive tariffs, creating immediate pressure on companies to assess their import strategies and existing government agreements.

The core exemption centers on "most-favored nation" (MFN) deals. Companies that have already struck such agreements to sell their drugs would be shielded from the new 100% import levy. This carve-out sets up a critical divide within the industry, favoring firms with established preferential pricing contracts with the government over those reliant on standard import channels for patented products. The policy appears designed to use tariff threats as leverage to push more manufacturers into MFN-style arrangements, which typically involve lower drug prices.

The impending order signals a significant escalation in using trade policy to target drug costs, moving beyond rhetoric to concrete, disruptive action. For global pharmaceutical companies, the risk is a sudden, severe cost increase on key imported components and finished goods, potentially disrupting supply and forcing rapid operational adjustments. The development places immediate scrutiny on which firms have MFN deals in place and which do not, with market advantages shifting accordingly. The coming days will reveal the final scope and whether the administration follows through on a threat that could reshape portions of the U.S. pharmaceutical import landscape.
---
- **Source**: STAT News
- **Sector**: The Network
- **Tags**: pharmaceuticals, tariffs, trade policy, drug pricing, supply chain
- **Credibility**: unverified
- **Published**: 2026-04-02 13:57:35
- **ID**: 47493
- **URL**: https://whisperx.ai/en/intel/47493